Evidence map›Paper›PMID 39972315›Full record

ArticleBMC public health2025

Asbestos exposure, pleural plaques and digestive cancers.

Bénédicte Clin, Céline Gramond, Fleur Delva, Pascal Andujar, Isabelle Thaon, Patrick Brochard, Julia Benoist, Antoine Gislard, François Laurent, Ilyes Benlala and 2 more

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bénédicte ClinINSERM U1086 « ANTICIPE », Caen, F-14000, France. benedicte.clin14@orange.fr.
Céline GramondInserm U1219 - EPICENE Team, Université de Bordeaux, Bordeaux Cedex, Aquitaine, F-3300, France.
Fleur DelvaInserm U1219 - EPICENE Team, Université de Bordeaux, Bordeaux Cedex, Aquitaine, F-3300, France.
Pascal AndujarUniversité Paris-Est Créteil, INSERM, IMRB, Equipe GEIC2O, Créteil, F-94010, France.
Isabelle ThaonUniversité de Lorraine, Inserm, INSPIIRE, Nancy, FR-54000, France.
Patrick BrochardCHU Bordeaux, Bordeaux, F-3300, France.
Julia BenoistInstitut Interuniversitaire de Médecine du Travail de Paris-Ile de France, Créteil, F-94010, France.
Antoine GislardCHU Rouen, Service des maladies professionnelles, Rouen, F-76000, France.
François LaurentUniversité de Bordeaux, Faculté de Santé, Bordeaux, F-33000, France.
Ilyes BenlalaUniversité de Bordeaux, Faculté de Santé, Bordeaux, F-33000, France.
Christophe ParisCHU Rennes Ponchaillou, Service de santé au travail et pathologie professionnelle et environnementale, Rennes, F-35000, France.
Jean-Claude PaironUniversité Paris-Est Créteil, INSERM, IMRB, Equipe GEIC2O, Créteil, F-94010, France.

Funding

French Agency for Food, Environmental and Occupational Health & Safety 07-CRD-51
6 · The paper itself

Abstract

backgroundThe aim of this study was to analyse the incidence and mortality from various digestive cancer sites and their potential link with pleural plaques, in a French cohort of workers previously occupationally exposed to asbestos.

methodsWe conducted a 10-year follow-up study in 13,481 male subjects, included in the cohort between October 2003 and December 2005, for whom asbestos exposure was assessed by calculation of a cumulative exposure index (CEI) in equivalent fibres.years/mL for each subject. We conducted an incidence study and a mortality study. Complementary analysis was restricted to men who had performed at least one chest CT-scan (N = 4,794). We used a Cox model with age as the time axis variable, adjusted for smoking, time since first exposure (TSFE), CEI to asbestos and the existence of pleural plaques on CT-scan.

resultsIn the incidence study, a significant dose-response relationship was observed between CEI to asbestos and oesophageal cancer (HR 1.03, 95% CI [1.01-1.06]) in the entire cohort after adjustment for TSFE and smoking status. In subjects undergoing CT-scan, a significant association between pleural plaques was observed for oesophageal cancer incidence (HR 2.80, 95% CI [1.09-7.20]) and in the mortality study, multivariate analyses showed a significant dose-effect response between CEI to asbestos and death from oesophageal cancer (HR 1.03, 95% CI [1.00-1.05]) in the entire cohort.

conclusionsThis large-scale study confirms results concerning a likely relationship between asbestos exposure and oesophageal cancer, and the association between this cancer and pleural plaques after adjustment on CEI to asbestos.

Indexed as

AsbestosDigestive System NeoplasmsEsophageal NeoplasmsOccupational ExposurePleural DiseasesAdultAgedCohort StudiesFollow-Up StudiesFranceHumansIncidenceMaleMiddle AgedProportional Hazards ModelsTomography, X-Ray ComputedAsbestosAsbestosCancerDigestive cancerIncidenceMortalityOccupational exposureOesophageal cancerPleural plaque

Identifiers

PMID39972315
PMCPMC11841182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.